Proteomics Market (2023 to 2029) – Growth, Industry Analysis, Segmentation and Forecast

The Proteomics Market was valued at US$ 23.48 Bn in 2022. The Proteomics Market size is estimated to grow at a CAGR of 16.79% over the forecast period.
Proteomics Market Overview:
The report explores the Proteomics market's segments (Instrumentation Technology, Reagent, Software and Service, Application, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2020. The report investigates the Proteomics market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Proteomics market's contemporary competitive scenario.To know about the Research Methodology:-Request Free Sample Report
Proteomics Market Dynamics:
There has been an increase in cancer and genetic disorders in the past decade, one of which was the completion of the sequencing of the human genome. The next significant biomedicine milestone was the characterization of human proteins. This is a relatively new and extremely dynamic branch of science that focuses on evaluating gene expression at the proteome level. With only limited research performed in proteomics to date, current proteomics is limited to dealing with a number of issues, including protein identification, quantification, characterization of post-translational modifications, and description of potential interactions. It is expected that with increased research efforts, both monetary and technical, the field of proteomics will incorporate technologies that can be applied to serum and tissue samples. This will enable them to extract important biological information in the form of biomarkers to aid clinicians and scientists in understanding the dynamic biology of their systems of interest, such as cancer patients.

Nanoproteomics is gaining prominence as several proteomics applications have been developed using nanotechnologies, such as phosphoproteomics/metal oxide nanoparticles, nanostructure surfaces for protein separation, and array-based analysis of biomarker proteins. Nanoproteomics is a science that applies proteomics techniques to nanotechnology. This is used as a complementary component to revolutionize proteomics through nanotechnology applications, such as nonporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures.

Instruments are expensive, companies rely on accessible structural data and trial-and-error methods to determine which compounds stimulate or disable target proteins, and the structuring of proteins requires rapid, high-throughput tools and machines. One of the most widely used methods in proteomics is X-ray crystallography, which is used for gene cloning, protein expression, and purification and crystallization of proteins. All of these processes require a large number of laboratory hours, which increases the cost of testing each sample. Proteomics is a field that is difficult for developing countries to enter because of the high cost of instruments and reagents.
Impact of COVID-19:
Proteomics is a highly relevant technique in the fight against COVID-19 due to the importance of understanding the role proteins play in infection processes as well as disease progression. These insights are crucial for the development of new prevention strategies and therapeutics. The use of mass spectrometry to detect COVID-19 virus proteins and proteolytic peptides enables a rapid, simple virus detection assay. Proteomics, on the other hand, allows detection of the virus' spike proteins and nucleocapsid with high specificity and sensitivity in clinical and research samples.

This approach could be an effective diagnostic option for diagnostic laboratories and point-of-care testing as a cost-effective alternative to nucleic acid-based techniques. Proteomics may be used to develop techniques to predict COVID-19 patients who may experience severe symptoms later. Several studies have revealed that certain protein-based biomarkers are expressed differently among COVID-19 patients, which can be used to predict viral infection at an earlier stage. Utilizing proteomics to understand humoral antibody responses against virus proteins has enabled the development of specific antibody-based assays for diagnostic and therapeutic purposes.
Proteomics Market Segment Analysis:
Based on Instrumentation Technology, the Proteomics Market is segmented into X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation, Electrophoresis, Protein Microarrays, Spectroscopy, and Chromatography.

The Protein Microarray segment has the highest market share in 2022. The use of this technology also makes it possible to produce multiple findings from a limited sample, complete protein imprinting, label-free identification, and direct and total quantification. This technology provides high resolution and efficient separation of different proteins in complex structures, which will lead to its rapid growth during the forecast period.Based on Reagent, the Proteomics Market is segmented into Protein Microarray, X-Ray Crystallography, Electrophoresis, Protein Fractionation, Immunoassay, Spectroscopy, and Chromatography. The Immunoassay segment has the highest market share in 2022. This is largely due to the availability of a wide range of reagents and the need for reliable, specific, and fast detection of diseases at an early stage.

Based on End-user: the Proteomics Market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical Companies, and Others.

The Pharmaceutical Companies segment has the highest market share in 2022. As a result of the increased funding for genomics and proteomics research, as well as the increasing outsourcing of research activities to various pharmaceutical companies with in-house CRO services, this segment has grown significantly
Proteomics Market Regional Insights:
The North America region has the highest market share in 2022. A major factor driving the market growth in this region is the increased collaborations and partnerships activities by key players. For example, in November 2018, Thermo Fisher Scientific Inc. and Symphogen entered into a two-year collaboration to develop validated platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. Symphogen will have access to Thermo Fisher's Q Exactive Plus Orbit rap LC-MS/MS system with BioPharma Option for creating, testing, and validating workflows for intact and native mass spectrometry analysis of therapeutic monoclonal antibody (mAb) mixtures under this agreement. Further, Symphogen will develop automated multi-attribute method (MAM) workflows for monitoring critical quality attributes of proteins in a quality control environment using high-resolution accurate mass spectrometry.

The Asia Pacific region is witnessing the fastest-growing during the forecast period. Increasing government initiatives to promote research and development in proteomics, genomics, and bioinformatics is expected to drive the Asia Pacific proteomics market growth during the forecast period. For instance, the 13th International Conference on Proteomics, Genomics, and Bioinformatics will be placed in Tokyo, Japan, in May 2020. "Leading Edge Innovations in Life Sciences" is the theme of the conference, and the objective will be to explore the most recent advances and new methodologies that can be applied to the research to take proteomics and bioinformatics more advanced. This conference is intended for health professionals, researchers, scientists, business leaders, government or non-government community groups, professors, psychiatrists, and therapists.

The objective of the report is to present a comprehensive analysis of the global Proteomics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Proteomics Market dynamic, and structure by analyzing the market segments and projecting the Proteomics Market size. Clear representation of competitive analysis of key players by Design, price, financial position, Instrumentation Technology portfolio, growth strategies, and regional presence in the Proteomics Market make the report investor’s guide.
Proteomics Market Scope: Inquire before buying



Proteomics Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 23.48 Bn.


Forecast Period 2023 to 2029 CAGR:
16.79%
Market Size in 2029:
US $ 69.6 Bn.


 Segments Covered:
by Instrumentation Technology
X-Ray Crystallography
Surface Plasmon Resonance
Protein Fractionation
Electrophoresis
Protein Microarrays
Spectroscopy
Chromatography


by Reagent
Protein Microarray
X-Ray Crystallography
Electrophoresis
Protein Fractionation
Immunoassay
Spectroscopy
Chromatography


by Software and Service
Core Proteomics Services
Bioinformatics Software and Services


by Application
Clinical Diagnostics
Drug Discovery
Other


by End-User
Hospitals
Clinical Laboratories
Pharmaceutical Companies
Other



Proteomics Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Proteomics Market Key Players are:
1. Thermo Fisher Scientific Inc.
2. Bio-Rad Laboratories, Inc.
3. Merck KGaA
4. Agilent Technologies, Inc.
5. Bruker Corporation
6. Danaher Corporation
7. GE Healthcare
8. Luminex Corporation
9. PerkinElmer Inc.
10.Waters Corporation
11.Illumina, Inc.
12.Eurofins Scientific
13.QIAGEN Bioinformatics
14.Creative Proteomics
15.Promega Corporation
16.Sengenics
17.Biomax Informatics AG
18.MS Bioworks LLC
19.WuXi NextCODE
20.Fios Genomics Ltd.

Frequently Asked Questions:

1. What is the study period of the market?
Ans. The Global Proteomics Market is studied from 2022-2029.

2. What is the growth rate of Proteomics Market?
Ans. The Global Proteomics Market is growing at a CAGR of 16.79% over forecast period.

3. Which region has largest share in The Global Proteomics Market?
Ans. North America holds the largest share.

4. What is the Global Proteomics Market segment based on Application?
Ans. Based on Application, The Global Proteomics Market is divided into Clinical Diagnostics, Drug Discovery, Other.

5. Who are the key players in the Global Proteomics Market?
Ans. The key players in the Global Proteomics Market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Merck KGaA , Agilent Technologies, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, PerkinElmer Inc., Waters Corporation, Illumina, Inc., Eurofins Scientific, QIAGEN Bioinformatics, Creative Proteomics, Promega Corporation, Sengenics, Biomax Informatics AG, MS Bioworks LLC, WuXi NextCODE, Fios Genomics Ltd.